Panax ginseng shows highest effectiveness in treating Alzheimer's. Learn more about AVXL's blarcamesine and SAVA's simufilam ...

About Anavex Life Sciences Corp.

On Friday, Anavex Life Sciences Corp (AVXL) stock saw a modest uptick, ending the day at $9.24 which represents a slight increase of $1.60 or 20.94% from the prior close of $7.64. The stock opened at ...

The stock is currently trading at just under $27. AVXL: Anavex Life Sciences rounds out the list as another heavily-shorted ...

Anavex Life Sciences' (AVXL) stock surged on new Alzheimer's trial data, but data's inconsistency raises concerns, making the ...

University of Michigan researchers have added a new dimension to the mathematics used to predict the outcomes of all manner of competitions, including sports, games and social hierarchies in both ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 3.15% of ...

China Universal Asset Management Co. Ltd. lifted its position in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 64.0% during the 3rd quarter, according to the company in its most recent ...

Data of Blarcamesine confirm upstream SIGMAR1 activationPresented as Late Breaking Oral Communications at Clinical Trials on Alzheimer’s Disease ...

YXT.com Group Holding Limited ('YXT.com” or the 'Company”), a leader and disruptor of the digital corporate learning industry in China, today announced the appointment of Marcum Asia CPAs LLP ('Marcum ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...